2023 marked a year of significant progress in the field of HRT. Research advancements, clinical trials, and increased awareness are paving the way for more personalized, effective, and accessible treatment options for physicians administering hormone replacement therapy to improve their patients’ health and quality of life.

While progesterone has long been considered exclusively a female reproductive hormone, numerous studies now show that it has wide ranging neuroprotective properties in humans. In this article, we share some revelatory research on progesterone replacement therapy to improve neurological outcome after traumatic brain injury.

After age 40, men’s testosterone levels will begin to decrease. This decrease is linked to an increase in mortality and cardiovascular risks, as well as a greater risk of developing type 2 diabetes, coronary artery disease (CAD), and metabolic syndrome. Testosterone replacement can improve many of the cardiovascular diseases of older men.